MAGEA4 is known to mediate stabilization of RAD18 through inhibiting its ubiquitin-dependent proteolysis and promoting trans-lesion synthesis in the adenocarcinoma cell line H1299 (Gao et al, 2016). The gene discussed is RAD18; the disease is adenocarcinoma.